botulinum toxin type A — Drug Target
All drugs that target botulinum toxin type A — marketed and clinical-stage. Includes 3 drug classes acting on this target.
Drug classes
botulinum toxin type A inhibitor · Neurotoxin · Neuromuscular blocking agent
Phase 3 pipeline (4)
- DWC202405, DWC202314P · Daewoong Pharmaceutical Co. LTD. · botulinum toxin type A inhibitor · Neurology
DWC202405 is a botulinum toxin type A inhibitor. - DWC202404, DWC202314P · Daewoong Pharmaceutical Co. LTD. · botulinum toxin type A inhibitor · Neurology
DWC202404 is a botulinum toxin type A inhibitor. - DWC202313, DWC202314 · Daewoong Pharmaceutical Co. LTD. · botulinum toxin type A inhibitor · Neurology
DWC202313 and DWC202314 are botulinum toxin type A inhibitors. - DWC202313, DWC202314P · Daewoong Pharmaceutical Co. LTD. · botulinum toxin type A inhibitor · Neurology
DWC202313 and DWC202314P are botulinum toxin type A inhibitors.
Phase 2 pipeline (2)
- BOTOX® purified neurotoxin complex · Allergan · Neurotoxin · Neurology
Botulinum toxin type A inhibits acetylcholine release at the neuromuscular junction. - Botulinum Toxin Type A - Vistabel · Galderma R&D · Neuromuscular blocking agent · Neurology
Inhibits acetylcholine release at the neuromuscular junction